American skeptics fuel ongoing pharma 'trust deficit' despite pandemic gains, research finds

Despite the pandemic and the promise of a relationship reset, half of Americans still don’t trust pharma companies. That’s according to Deloitte focus group studies in the U.S., India, South Africa and the U.K.

While 80% of those surveyed in the other three countries said they trusted or were neutral toward pharma, Americans remain skeptical.